Two Sigma Advisers’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Hold |
11,400
| – | – | ﹤0.01% | 2177 |
|
|
2025
Q1 | $84.7K | Sell |
11,400
-40,200
| -78% | -$299K | ﹤0.01% | 2259 |
|
|
2024
Q4 | $309K | Buy |
51,600
+41,200
| +396% | +$247K | ﹤0.01% | 1967 |
|
|
2024
Q3 | $53.2K | Buy |
+10,400
| New | +$53.2K | ﹤0.01% | 2211 |
|
|
2024
Q2 | – | Sell |
-10,800
| Closed | -$34.7K | – | 2417 |
|
|
2024
Q1 | $34.7K | Buy |
10,800
+800
| +8% | +$2.57K | ﹤0.01% | 2370 |
|
|
2023
Q4 | $49K | Buy |
+10,000
| New | +$49K | ﹤0.01% | 2398 |
|
|
2023
Q3 | – | Sell |
-14,800
| Closed | -$99.3K | – | 2370 |
|
|
2023
Q2 | $99.3K | Sell |
14,800
-1,100
| -7% | -$7.38K | ﹤0.01% | 2215 |
|
|
2023
Q1 | $140K | Sell |
15,900
-19,800
| -55% | -$175K | ﹤0.01% | 2327 |
|
|
2022
Q4 | $273K | Sell |
35,700
-15,400
| -30% | -$118K | ﹤0.01% | 2098 |
|
|
2022
Q3 | $364K | Buy |
51,100
+4,700
| +10% | +$33.5K | ﹤0.01% | 1973 |
|
|
2022
Q2 | $375K | Buy |
46,400
+34,300
| +283% | +$277K | ﹤0.01% | 2047 |
|
|
2022
Q1 | $168K | Buy |
+12,100
| New | +$168K | ﹤0.01% | 2418 |
|
|
2021
Q2 | – | Sell |
-35,600
| Closed | -$1.43M | – | 2426 |
|
|
2021
Q1 | $1.43M | Buy |
+35,600
| New | +$1.43M | ﹤0.01% | 1443 |
|